Harmony Biosciences Holdings, Inc. (HRMY)

Pharmaceutical Preparations

Latest Price

$41.52

TTM P/E

13.48

Normalized P/E

16.80

Div Yield

Book Value

17.27

P/B Ratio

2.40

Valuation metrics

EPS: $2.71

Book value / share: $15.07

Formula: √(22.5 × EPS × BVPS)

Graham Number

$30.32

28% downside

Norm. op. income: $156M (median of 6yr)

Tax rate: 25%

Discount rate: 10%

Growth assumption: zero (EPV is a no-growth value)

Earnings Power Value

$30.82

27% downside

Base FCF: $219M (median of recent 5yr)

Growth: 25%/yr (median YOY, capped at 25%)

Discount rate: 10%

Terminal growth: 3%

Projection horizon: 10 years

DCF Fair Value

$292.51

+594% upside

EPS: $2.71

Target P/E: 17×

Formula: EPS × P/E

P/E Fair Value

$46.07

+9% upside

92.8% held by institutions

Institution	Shares	Value	Ownership %	Change	Filing Date
BlackRock, Inc.	7.10M	$258.0M	12.22%	+31.9K	2026-06-30
FMR LLC	3.57M	$130.0M	6.15%	+416.5K	2026-06-30
VANGUARD PORTFOLIO MANAGEMENT LLC	2.88M	$104.0M	4.96%	+166.1K	2026-06-30
AMERICAN CENTURY COMPANIES INC	2.54M	$92.0M	4.37%	+434.3K	2026-06-30
DIMENSIONAL FUND ADVISORS LP	2.39M	$87.0M	4.12%	+317.1K	2026-06-30
VANGUARD CAPITAL MANAGEMENT LLC	2.11M	$76.0M	3.62%	+2.7K	2026-06-30
LSV ASSET MANAGEMENT	2.06M	$75.0M	3.55%	+36.1K	2026-06-30
STATE STREET CORP	1.86M	$67.0M	3.20%	+75.0K	2026-06-30
ARMISTICE CAPITAL, LLC	1.56M	$56.0M	2.69%	-60.0K	2026-06-30
GEODE CAPITAL MANAGEMENT, LLC	1.44M	$52.0M	2.48%	+119.9K	2026-06-30